Whatever Happened to Measuring Ventricular Contractility in Heart Failure?
Author:
- 1 January 2017
- journal article
- Published by Radcliffe Medical Media Ltd in Cardiac Failure Review
- Vol. 3 (2) , 79-82
Abstract
This review will discuss the difficulty in measurement, the complicated nature of myocardial fibre orientation and hypertrophy, and whether myocardial contractility failure precipitates increased global heart failure.Keywords
This publication has 19 references indexed in Scilit:
- What Is the Role of β-Adrenergic Signaling in Heart Failure?Circulation Research, 2003
- Beneficial Effect of the Calcium-Sensitizing Drug EMD 57033 in a Canine Model of Dilated Heart FailureClinical Science, 1997
- Value of Digoxin in Heart Failure and Sinus Rhythm: New Features of an Old Drug?JACC, 1996
- Tachycardia-induced failure alters contractile properties of canine ventricular myocytes.1996
- EMD 57033 Enhances Arrhythmias Associated with Increased Wall-Stress in the Working Rat HeartClinical Science, 1995
- Responses to changes in filling and contractility of indices of human left ventricular mechanical performance.The Journal of Physiology, 1990
- Velocity of sarcomere shortening in rat cardiac muscle: relationship to force, sarcomere length, calcium and time.The Journal of Physiology, 1984
- The effect of carbon dioxide upon myocardial contractile performance, blood flow and oxygen consumption.The Journal of Physiology, 1979
- Maximum Acceleration of Blood from the Left Ventricle in Patients with Ischaemic Heart DiseaseClinical Science, 1974
- Reexamination of the Applicability of the HIII Model of Muscle to Cat MyocardiumCirculation Research, 1972